Overview


Advancements in the administration of intravenous medication, rising insistence for IV pumps from physicians, nurse anaesthetists and anaesthesiologist, soaring acceptance of smart pumps are some of the key factors responsible for the growth of the market. Furthermore, the emergence of reduction systems with less dosage errors shall bolster the next-generation IV infusion pumps market growth. IV infusion pumps are developed for improving system usability and infusion efficiency. These systems offer database of patient infusions for insightful decisions in managing chronic disorders. The emergence of dosage guidance in real-time and immediate feedback received from automatic drug libraries shall aid in the compliance of drugs used. This technology has also aided in the reduction of manual labour with the automatic documentation with EMR and BCMA. Such factors shall positively impact the market growth.
Next-Generation IV Infusion Pumps Market
By Product
Large Volumetric Infusion Systems
Syringe Infusion Systems
Electronic Ambulatory Infusion Systems
Patient Controlled Analgesia Pumps
Disposable Elastomeric Infusion Systems
Implantable Infusion Systems
MRI-Compatible IV Infusion Pump Systems
IV Disposables
By Application
Clinical Nutrition
Pain Management
Chemotherapy
Antibiotic Management
Others
By End User
Hospitals
Ambulatory Surgical Centers
Homecare Settings
Diagnostic Centers
Others
By Region

North America

Europe
Asia Pacific
Latin America
Middle East
Africa
The market is classified into product, application, end user and region. The product segment is categorised into large volumetric infusion systems, syringe infusion systems, electronic ambulatory infusion systems, patient controlled analgesia pumps, disposable elastomeric infusion systems, implantable infusion systems, MRI-compatible IV infusion pump system, IV disposables. The application segment is fragmented into clinical nutrition, pain management, chemotherapy, antibiotic management and others. The end user segment is categorised into hospitals, ambulatory surgical centres, homecare settings, diagnostic centres and others.
The North America region is predicted to hold the largest next-generation IV infusion pumps market share owing to the growing prevalence of appalling diseases, soaring geriatric population, rising access to advanced healthcare facilities, escalating insistence from clinicians. Furthermore, rising R D activities, improving insurance policies shall boost the market growth in the region.
The major market players associated are
Baxter International Inc. ,
Becton Dickinson and Co. ,
Fresnius Kabi AG ,
B. Braun Melsungen AG , Smiths Medical, ICU Medical, iRadimed Corp., Zyno Medical, Medtronic PLC, Terumo Corp., Nipro Corp., Summit Medical Products Inc., Ambu A/S, Gamastech SRL, vTian, ACromed AG.
Growth prospects
SWOT analysis
Key market trends
Key data-points affecting market growth
To provide with an exhaustive analysis on the global next-generation IV infusion pumps market by product, by application, by end user and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
To record, evaluate
and analyze
competitive landscape mapping- product launches, technological advancements, mergers and expansions
We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Market Variables, Trends
    • Scope
        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework on Country Level
         6.1 . Reimbursement Framework
         6.2 . Standards and Compliances
  • 5.   Market Overview
    •   1. Market Dynamics
         1.1 . Market Driver Analysis
         1.2 . Market Restraint Analysis
         1.3 . Industry Challenges
  • 6.   Market Analysis tools
    •   1. Industry Analysis - Porter’s
         1.1 . Supplier Power
         1.2 . Buyer Power
         1.3 . Substitution Threat
         1.4 . Threat from new entrants
         1.5 . Competitive Rivalry
        2. Pestel Analysis
         2.1 . Political Landscape
         2.2 . Environmental Landscape
         2.3 . Social landscape
         2.4 . Technology landscape
         2.5 . Legal Landscape
  • 7.   Next-Generation IV Infusion Pumps Market, By Product Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
    •   1. Large Volumetric Infusion Systems
        2. Syringe Infusion Systems
        3. Electronic Ambulatory Infusion Systems
        4. Electronic Ambulatory Infusion Systems
        7.5 . Patient Controlled Analgesia Pumps
        7.6 . Disposable Elastomeric Infusion Systems
        7. Implantable Infusion Systems
        8. MRI-Compatible IV Infusion Pump Systems
        9. IV Disposables
  • 8.   Next-Generation IV Infusion Pumps Market, By Application Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
    •   1. Clinical Nutrition
        2. Pain Management
        3. Chemotherapy
        4. Antibiotic Management
        8.5 . Others
  • 9.   Next-Generation IV Infusion Pumps Market, By End User Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million)
    •   1. Hospitals
        2. Ambulatory Surgical Centers
        3. Homecare Settings
        4. Diagnostic Centers
        5. Others
  • 10.   North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019
           2.1. U.S.
         2.2. Canada
         2.3. Mexico
         2.4 . Rest of North America
        10.3 . Market Size (USD Mn) Forecast for North America 2020-2027
  • 11.   Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    •   1. Introduction
        2. Regional Market Trends
        3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
         3.1. Brazil
         3.2. Uruguay
         3.3 . Argentina
         3.4. Rest of Latin America
        11.4 . Market Size (US$ Mn) Forecast for Latin America 2020-2027
  • 12.   Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    •   1. Introduction
        2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019
         2.1. Germany
          2.2. U.K
         2.3. France
         2.4. Italy
         2.5 . Switzerland
         2.6. Spain
         2.7. Russia
         2.8. Poland
         2.9. Rest of Western Europe
        12.3 . Market Size (US$ Mn) Forecast for North America 2020-2027
  • 13.   Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    •   13.1 . Introduction
        13.2 . Historical Market Size (USD Mn) Analysis By Country, 2015-2019
         2.1 . Japan
         2.2 . China
         2.3 . Singapore
         2.4 . Korea
         2.5 . India
         2.6 . Australia and New Zealand
         2.7 . ASEAN
         2.8 . Rest of Asia Pacific
        13.3 . Market Size (US$ Mn) Forecast for North America 2020-2027
  • 14.   Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
    •   14.1 . Introduction
        14.2 . Historical Market Size (USD Mn) Analysis By Country, 2015-2019
         2.1 . UAE
         2.2 . South Africa
         2.3 . Egypt
         2.4 . Saudi Arabia
         2.5 . Rest of MEA
        14.3 . Market Size (US$ Mn) Forecast for MEA 2020-2027
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
    •    15.1 . Baxter International Inc.
         1.1. Company Overview (HQ, Business Segments, Employee Strength)
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
         15.2 . Becton Dickinson and Co.
         2.1. Company Overview (HQ, Business Segments, Employee Strength)
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        15.3 . Fresnius Kabi AG
         3.1. Company Overview (HQ, Business Segments, Employee Strength)
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
         15.4 . B. Braun Melsungen AG
         4.1. Company Overview (HQ, Business Segments, Employee Strength)
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        15.5 . Smiths Medical
         5.1. Company Overview (HQ, Business Segments, Employee Strength)
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        15.6 . ICU Medical
         6.1. Company Overview (HQ, Business Segments, Employee Strength)
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
         15.7 . iRadimed Corp.
         7.1. Company Overview (HQ, Business Segments, Employee Strength)
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        15.8 . Zyno Medical
         8.1. Company Overview (HQ, Business Segments, Employee Strength)
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        15.9 . Medtronic PLC
         9.1. Company Overview (HQ, Business Segments, Employee Strength)
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        15.10 Terumo Corp.
         10.1. Company Overview (HQ, Business Segments, Employee Strength)
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
      16 Impact of COVID-19
        16.1. Positive influence on the healthcare industry
        16.2. The financial disruption of the manufacturing sector
        16.3. Impact of COVID-19 on emerging companies
        16.4. Significant mandates in the healthcare regulations initiated by administrations
        16.5. The overall economic slowdown of the developing and developed nations
      17 Competitive Intelligence and Competitive Matrix
        17.1 . Competitive Intelligence
        17.2 . Competitive Matrix
  • 16.   Major Deals and Strategic Alliances Analysis
    •   18.1 . Joint ventures
        18.2 . Mergers and acquisitions
        18.3 . Licensing and partnerships
        18.4 . Technology Collaborations
        18.5 . Strategic Divestments
        18.6 . Market Entry Strategies
  • 17.   Relevant Case Studies and Latest News Updates
  • 18.   Key Market Takeaway Points from the Market Analysts at Future Market Analytics
Partner

Our Clients